Propionibacterium acnes (P. acnes) resistance and antibiotic use in patients attending Australian general practice

Australasian Journal of Dermatology

Volumn 53, Issue 2, 2012, Pages 106-111

  Toyne, Helen ^a   Webber, Cameron ^a   Collignon, Peter ^b   Dwan, Kathryn ^c   Kljakovic, Marjan ^a  

^a Canberra Hospital   (Australia)

^b CANBERRA HOSPITAL   (Australia)

^c AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

acne; antibiotic resistance; general practice; primary care

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; DOXYCYCLINE; ERYTHROMYCIN; METICILLIN; MINOCYCLINE; PENICILLIN G; TETRACYCLINE;

ACNE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM ISOLATION; CLINICAL CLASSIFICATION; CORYNEBACTERIUM; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GENERAL PRACTICE; HUMAN; MAJOR CLINICAL STUDY; MALE; NOSE SMEAR; OBSERVATIONAL STUDY; PRESCRIPTION; PROPIONIBACTERIUM ACNES; QUESTIONNAIRE; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

ACNE VULGARIS; ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; AUSTRALIAN CAPITAL TERRITORY; DRUG RESISTANCE, BACTERIAL; FEMALE; GENERAL PRACTICE; HUMANS; MALE; NEW SOUTH WALES; PROPIONIBACTERIUM ACNES; STAPHYLOCOCCUS AUREUS; YOUNG ADULT;

EID: 84861100675     PISSN: 00048380     EISSN: 14400960     Source Type: Journal    
DOI: 10.1111/j.1440-0960.2011.00867.x     Document Type: Article

References (25)

1. Goodman G,. Acne-natural history, facts and myths. Aust. Fam. Physician 2006; 35: 613-16.
2. Australasian College of Dermatologists. A-Z of skin: acne. Sydney, Australasian College of Dermatologists,2001; Available from URL:. (Accessed 17 December 2010.)
3. Bettering the Evaluation and Care of Health (BEACH). Acne in Patients Attending General Practice April 2007-March 2008. Sydney, Australia: Australian General Practice Statistics and Classification Centre, Family Medicine Research Centre. University of Sydney at Westmead Hospital, 2008.
4. Marks RPA, Merlin K, Jenner N,. Atlas of Common Skin Diseases in Australia. Melbourne, Australia: Department of Dermatology, St Vincent's Hospita, 1999; Available from URL:. (Accessed 17 December 2011.)
5. Katsambas AD, Stefanaki C, Cunliffe WJ,. Guidelines for treating acne. Clin. Dermatol. 2004; 22: 439-44. (Pubitemid 39535288)
6. Lehmann HP, Robinson KA, Andrews JS, et al,. Acne therapy: a methodologic review. J. Am. Acad. Dermatol. 2002; 47: 231-40.
7. Brown JM, Poston SM,. Resistance of propionibacteria to antibiotics used in the treatment of acne. J. Med. Microbiol. 1983; 16: 271-80. (Pubitemid 13032669)
8. Coates P, Vyakrnam S, Eady EA, et al,. Prevalence of antibiotic-resistant propionibacteria on the skin of acne patients: 10-year surveillance data and snapshot distribution study. Br. J. Dermatol. 2002; 146: 840-8. (Pubitemid 34539195)
9. Eady EA, Gloor M, Leyden JJ,. Propionibacterium acnes resistance: a worldwide problem. Dermatology 2003; 206: 54-6. (Pubitemid 36164666)
10. Gubelin W, Martinez MA, Molina MT, et al,. Antimicrobial susceptibility of strains of Propionibacterium acnes isolated from inflammatory acne. Rev. Latinoam. Microbiol. 2006; 48: 14-16. (Pubitemid 47264142)
11. Ishida N, Nakaminami H, Noguchi N, et al,. Antimicrobial susceptibilities of Propionibacterium acnes isolated from patients with acne vulgaris. Microbiol. Immunol. 2008; 52: 621-4.
12. Eady AE, Cove JH, Layton AM,. Is antibiotic resistance in cutaneous propionibacteria clinically relevant?: implications of resistance for acne patients and prescribers. Am. J. Clin. Dermatol. 2003; 4: 813-31. (Pubitemid 38030858)
13. Vohra RCP, Webber C,. Emerging resistance in P. acnes. ACT Pathology Newsletter. 1999 April (46): 4-5.
14. Pochi PE, Shalita AR, Strauss JS, et al,. Report of the Consensus Conference on Acne Classification. Washington, DC, March 24 and 25, 1990. J. Am. Acad. Dermatol. 1991; 24: 495-500.
15. Burke BM, Cunliffe WJ,. The assessment of acne vulgaris-the Leeds technique. Br. J. Dermatol. 1984; 111: 83-92. (Pubitemid 14086231)
16. Jorgensen, JH., Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria; Approved Guideline, M45-A. Wayne, PA: CSLI 2006.
17. Sackett D, Richardson W, Rosenberg W, et al. (eds). Evidence-based Medicine-how to Practice and Teach EBM. New York: Churchill Livingstone, 1997.
18. Nasrin D, Collignon PJ, Roberts L, et al,. Effect of beta lactam antibiotic use in children on pneumococcal resistance to penicillin: prospective cohort study. BMJ 2002; 324: 28-30. (Pubitemid 34048851)
19. Therapeutic Guidelines Limited. Dermatology version 3, March 2009. Available from URL:. (Accessed 17 December 2011
20. Australian Medicines Handbook Pty Ltd. Australian Medicines Handbook, 2009. Available from URL:. (Accessed 17 December 2011.)
21. Australian Government Department of Health and Ageing. PBS for Health Professionals. Available from URL:. (Accessed 22 January 2010.)
22. Hawkey PM,. Molecular epidemiology of clinically significant antibiotic resistance genes. Br. J. Pharmacol. 2008; 153 (Suppl. 1): S406-13. (Pubitemid 351341006)
23. Kim J,. Acne vaccines: therapeutic option for the treatment of acne vulgaris? J. Invest. Dermatol. 2008; 128: 2353-4.
24. Nakatsuji T, Liu YT, Huang CP, et al,. Vaccination targeting a surface sialidase of P. acnes: implication for new treatment of acne vulgaris. PLoS ONE 2008; 3: e1551.
25. World Health Organization. WHO Global Strategy for Containment of Microbial Resistance. 2001; Available from URL:. (Accessed 17 December 2011)